Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models

Introduction Physiologically based pharmacokinetic (PBPK) modeling is a paradigm shift in this era for determining the exposure of drugs in pediatrics, geriatrics, and patients with chronic diseases where clinical trials are difficult to conduct.